TY - JOUR
T1 - Synthesis of 3-indolylmethyl substituted (pyrazolo/benzo)triazinone derivatives under Pd/Cu-catalysis
T2 - Identification of potent inhibitors of chorismate mutase (CM)
AU - Reddy, Gangireddy Sujeevan
AU - Snehalatha, Ampalam Venkata
AU - Edwin, Rebecca Kristina
AU - Hossain, Kazi Amirul
AU - Giliyaru, Varadaraj Bhat
AU - Hariharapura, Raghu Chandrashekhar
AU - Gautham Shenoy, G.
AU - Misra, Parimal
AU - Pal, Manojit
PY - 2019/10/1
Y1 - 2019/10/1
N2 - The chorismate mutase (CM) is considered as an attractive target for the identification of potential antitubercular agents due to its absence in animals but not in bacteria. A series of 3-indolylmethyl substituted pyrazolotriazinone derivatives were designed and docked into CM in silico as potential inhibitors. These compounds were efficiently synthesized using the Pd/Cu-catalyzed coupling-cyclization in a single pot involving the construction of indole ring. The methodology was later extended to the preparation of corresponding benzo analogs of pyrazolotriazinones i.e. 3-indolylmethyl substituted benzotriazinone derivatives. Several of these novel compounds showed significant inhibition of CM when tested in vitro at 30 µM. The SAR (Structure-Activity-Relationship) studies suggested that benzotriazinone moiety was more favorable over the pyrazolotriazinone ring. The two best active compounds showed IC50 ∼ 0.4–0.9 µM (better than the reference/known compounds used) and no toxicity till 30 µM in vitro.
AB - The chorismate mutase (CM) is considered as an attractive target for the identification of potential antitubercular agents due to its absence in animals but not in bacteria. A series of 3-indolylmethyl substituted pyrazolotriazinone derivatives were designed and docked into CM in silico as potential inhibitors. These compounds were efficiently synthesized using the Pd/Cu-catalyzed coupling-cyclization in a single pot involving the construction of indole ring. The methodology was later extended to the preparation of corresponding benzo analogs of pyrazolotriazinones i.e. 3-indolylmethyl substituted benzotriazinone derivatives. Several of these novel compounds showed significant inhibition of CM when tested in vitro at 30 µM. The SAR (Structure-Activity-Relationship) studies suggested that benzotriazinone moiety was more favorable over the pyrazolotriazinone ring. The two best active compounds showed IC50 ∼ 0.4–0.9 µM (better than the reference/known compounds used) and no toxicity till 30 µM in vitro.
UR - http://www.scopus.com/inward/record.url?scp=85071704665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071704665&partnerID=8YFLogxK
U2 - 10.1016/j.bioorg.2019.103155
DO - 10.1016/j.bioorg.2019.103155
M3 - Article
C2 - 31400552
AN - SCOPUS:85071704665
SN - 0045-2068
VL - 91
JO - Bioorganic Chemistry
JF - Bioorganic Chemistry
M1 - 103155
ER -